AstraZeneca Seeks Emergency Authorization for its Cocktail Drug in US
The company AstraZeneca has now submitted the company’s antibody cocktail for the emergency authorization of the United States for the purpose of preventing the novel corona virus infection as the options of therapeutic for the covid-19 pandemic. It has been the first regulatory filing for the medicine of the novel corona virus, that had been […]
Continue Reading